Table 2.
Summary of clinical features for the 69 patients with glioneuronal tumours for which clinical data was available
| Clinical features | Ganglioglioma | DNET | GNT NOS |
|---|---|---|---|
| Gender (n = 69) | 19 M/13F | 6 M/8F | 11 M/12F |
| Presented with seizures (n = 69) | 25 (n = 32) | 13 (n = 14) | 22 (n = 23) |
| Age 1st seizure (n = 60) (months) | 56 (3–188) (n = 26) | 78 (24–168) (n = 13) | 24 (0.5–180) (n = 21) |
| Age surgery (n = 62) (months) | 118 (20–201) (n = 26) | 130 (41–188) (n = 13) | 101 (17–212) (n = 23) |
| Seizure duration (n = 59) (months) | 68 (8–162) (n = 25) | 52 (1–146) (n = 13) | 61 (5–165) (n = 21) |
| Residual post-op tumour (n = 55) | 9 (n = 23) | 7 (n = 12) | 12 (n = 20) |
| Seizure free at 1 year (n = 60) | 16 (n = 25) | 7 (n = 13) | 12 (n = 22) |
| Seizure free at last follow-up (n = 60) | 15 (n = 25) | 6 (n = 13) | 12 (n = 22) |